Abstract. The cancer stem cell hypothesis has evolved to one of the most important paradigms in biomedical research. During recent years evidence has been accumulating for the existence of stem cell-like populations in different cancers, especially in leukemias. In the current work we propose a mathematical model of cancer stem cell dynamics in leukemias. We apply the model to compare cellular properties of leukemic stem cells to those of their benign counterparts. Using linear stability analysis we derive conditions necessary and sufficient for expansion of malignant cell clones, based on fundamental cellular properties. This approach reveals different scenarios of cancer initiation and provides qualitative hints to possible treatment strategies.
Introduction
Tissues of complex organisms consist of different types of specialized cells. In many tissues a small population of unspecialized cells, so called adult stem cells (tissue stem cells) gives rise to all cell types of the tissue. Adult stem cells are characterized by the potential to produce different cell types and the ability to maintain the size of their population by a process referred to as self-renewal. Adult stem cells ensure tissue maintenance and regeneration [56, 51] . Formation of mature specialized cells is a multi-step process starting from stem cells that give rise to a hierarchy of immature progenitor cells which develop into mature cells. The hematopoietic (blood-forming) system with hematopoietic stem cells at the top of the hierarchy is a known example of a multistage system.
During last years the concept of tissue stem cells has been extended to the concept of cancer stem cells (cancer initiating cells). According to this hypothesis a small population of "stem-like" cancer cells gives rise to the bulk of malignant cells [18, 20] . Since cancer stem cells may be difficult to access by classical treatment strategies, they are thought to be responsible for relapse of malignancies [17, 63] . Cancer stem cells have already been described in the context of different cancers [18, 15, 33] .
Because of relative facility of sampling blood or bone marrow, the hematopoietic system is well suited for modeling and validation. Hematopoiesis involves complex processes that can be examined at the level of genes, signal transduction proteins, or the populations of diverse cell types. By viewing hematopoiesis as a dynamical system and stress and disease as a perturbation of the system, the system biology approach may contribute to a better understanding of physiological and pathological states of hematopoiesis such as leukemias.
Depending on specific scientific questions, different mathematical models were developed to study hematopoiesis. One established method of modeling of multistage cell systems is to use a discrete collection of ordinary differential equations, each of which describes dynamics of cells at a single maturation stage [8, 22, 39, 43, 47, 64, 50] . Describing cell differentiation as a continuous process leads to models based on partial differential equations of the transport type [3, 11, 25, 24] or delay differential equations [27, 44, 4, 2, 55, 6] . Another group of models addresses the effects of stochasticity in the cell fate decisions [65, 66] or in the regulation of cell quiescence [59] . These models were designed to simulate the time dynamics of blood reconstitution, spread of cancer stem cells or perturbations in the blood dynamics in diseases such as e.g., myeloid leukemias, and provided explanations for a range of experimental and clinical observations. Whenever cell numbers are small, stochasticity plays an important role. This is, e.g., the case at the outset of cancer or before complete extinction of malignant clones. Reference [23] discusses a mathematical model for these scenarios, based on the Moran process taking into account differences in the reproductive fitness of different subpopulations. As proposed in ref. [32] , stochastic models allow localizing the origin of leukemia stem cells in the cellular hierarchy of the hematopoietic system at the level of progenitor cells. So called agent-based models allow considering cellular heterogeneity and environmental interactions at the single-cell level. Fitted to experimental data, they can provide insights into clinical scenarios such as imatinib treatment [58] . Enormous computational costs for systems with large cell numbers make it necessary to approximate them by continuous partial differential equation (PDE) (or ordinary differential equation; ODE) models [57] .
In the current work we investigate how changes in parameters describing proliferation rates and self-renewal properties may influence the dynamics of healthy and leukemic cell populations. For this task we propose a mathematical model that is an extension of our models of healthy hematopoiesis. Although the model focuses on the biology of the hematopoietic system, it may be relevant for other cellular systems, since different stem cell systems share common traits [56, 51] .
The paper is organized as follows: In Section 2. we introduce a model of leukemia and compare it to the model of healthy hematopoiesis proposed in ref. [47] and analyzed in ref. [64, 30, 54] . In Section 3. we investigate the existence of multiple steady states and analyze which cell properties are necessary and sufficient to destabilize the physiological equilibrium of healthy cells. We interpret the mathematical results and conclude in which respect the dynamics of cancer stem cells may differ from the dynamics of tissue stem cells and healthy progenitors. Based on the mathematical results we discuss different scenarios of cancer initiation and give examples of hematologic malignancies which may follow these scenarios. We perform linear stability analysis of the system consisting of stem cells, mature cells, leukemic stem cells and a population of non-stem leukemic cells. In Section 4. we present numerical solutions illustrating the results of the analysis. We conclude in Section 5. with summary and final comments. Technical proofs are deferred to the Appendix.
Model
In the following we develop a mathematical model of time dynamics of leukemic cell populations. The model is an extension of our models of healthy hematopoiesis [47, 48, 64] . Based on the classical understanding of hematopoiesis we assume that the hematopoietic system consists of an ordered sequence of discrete maturation states, so called compartments, which are sequentially traversed [34] . We treat each compartment as a "well-mixed tank" and describe time evolution using ordinary differential equations. The enormous amount of cells forming the hematopoietic system [34, 41] , justifies this approach. The model includes one leukemic cell lineage and one healthy cell lineage. We assume that the healthy hematopoietic cell line consists of n compartments, where the first compartment is the population of hematopoietic stem cells (HSC) and the nth compartment is the population of post-mitotic mature cells, e.g., mature white blood cells. Similarly, we assume that the leukemic cell line consists of m compartments, where leukemia initiating cells (LIC, "leukemic stem cells") are the first compartment. We denote by c i (t) (i = 1, . . . , n) the cell densities in the compartment i of the healthy hematopoiesis at time t and by l i (t) (i = 1, . . . , m) the corresponding cell densities in the leukemic lineage.
Healthy cells in compartment i are characterized by the following properties.
• p c i (t): Proliferation rate in compartment i at time t, describing how often a cell divides per unit of time. We assume that cells of the most mature compartment are post-mitotic, i.e. p c n (t) ≡ 0.
• a c i (t): Fraction of self-renewal in compartment i at time t, i.e., the fraction of daughter cells returning to the compartment occupied by the mother cells that gave rise to them. Based on our earlier work [47] we assume that the fraction of self-renewal is regulated by feedbacksignaling.
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Healthy Hematopoiesis Population Dynamics
Based on the notation specified above, the flux to mitosis in compartment i < n at time t equals p c i (t)c i (t). During mitosis the mother cell disappears and gives rise to two daughter cells. The outflux from mitosis at time t equals 2p c i (t)c i (t), of which the fraction 2a
) p c i (t)c i (t) moves to compartment i + 1 (process referred to as differentiation). Since stem cells are the most primitive cells, there exists no influx to the stem cell compartment due to differentiation. With the additional assumption that the most mature cells are post-mitotic, time evolution of the healthy hematopoietic compartments is described by the following system of equations, 
Signal Feedback
Formation of healthy blood cells is regulated by a negative feedback [42, 49, 28] . If there is a need for more blood cells of a certain type, the concentration of signaling molecules, so called cytokines, increases and stimulates formation of mature cells. It is accepted that the rate of expansion of progenitor cells increases, if cytokine concentrations increase, either by enhanced proliferation or by reduced apoptosis [28, 34, 5] . Important examples of hematopoietic cytokines are erythropoietin (EPO) for erythropoiesis (red blood cell formation) and granulocyte colony stimulating factor (G-CSF) for granulopoiesis (formation of granulocytes, one type of white blood cells). However, the precise nature of this regulation is still unknown. As concluded from our work on healthy hematopoiesis [47, 64, 46] , the positive equilibrium can be stable in the models with a single nonlinear feedback inhibition of self-renewal fractions or of division rates. In the two-compartment model, the positive equilibrium is always stable. On the other hand, in the three-compartment model, emergence of an instability region in a parameter plane is possible [54] . These stability results were extended to a global stability in case of the two-compartment model [30] . Moreover, numerical solutions of the proposed model, validated based on the clinical observations of hematopoiesis after bone marrow transplantation [47, 46] , indicate that the regulation of self-renewal is a more efficient mechanism than the regulation of proliferation rates. Similar conclusions were drawn using the models of multistage cell lineages applied to regeneration and maintenance of the mouse olfactory epithelium [39, 43] .
Therefore, in the remainder of this paper we assume that the regulatory mechanism is based on the feedback inhibition of self-renewal depending on the level of mature cells. For simplicity we take only one cytokine into account. Based on knowledge of G-CSF [49, 42, 62] , we assume that cytokine molecules are produced at a constant rate α, degraded at a constant rate β and eliminated proportionally to the density of mature cells at a constant positive rate µ. Following [47] , we obtain a time evolution of cytokine concentration given by
where cytokine concentration at time t is denoted by S(t). Since cytokine dynamics is fast in comparison to cell cycle duration, [14, 52] , we apply a quasi-steady state approximation. Substitution of s(t) := µ α S(t) and k := β µ leads to
Since the exact relationship of cell properties and signal concentration is not known, we parsimoniously assume it to be linear, i.e. a In the present work we focus on the impact of self-renewal on time dynamics of leukemia and assume proliferation rates to be constant in time. This results in the following model of healthy hematopoiesis,
initiating cell, LIC) is the most primitive leukemic cell and gives rise to all leukemic cell types.
In the present model we assume that leukemic cells are stimulated by the same cytokines as healthy HSC. In other words, we assume that healthy cells and leukemic cells compete for environmental resources, being the hematopoietic cytokine s(t). To model this competition we assume degradation of s(t) by leukemic cells. Based on the steady state assumption we obtain:
if we neglect signal degradation by primitive leukemic cell types, or otherwise
where k c and k l i are nonnegative constants.
Full Model
The assumptions listed above result in the following model of the healthy and the leukemic cell population coupled by the signal s(t): 
where
There exist also steady states with eitherl
(ii) Assume that for all pairs i, j,
Proof. The result is obtained from calculation of steady states. We now ask, when the steady states from Proposition 7 are nonnegative. 
•
Self-renewal in the leukemic cell line is enhanced in comparison to healthy cells due to mutation or impairment of differentiation. The latter is very common for leukemias and
therapeutically exploited in acute promyelocytic leukemia, [1] .
• Scenario 1: Reduced apoptosis in leukemia cells due to mutations (as observed in B-CLL, [53])

• Scenario 2: Induction of apoptosis in healthy cells by malignant cells (as observed in myelodysplastic syndromes, [67])
Example 16. a
• Proliferation in malignant cells is enhanced in comparison to healthy cells (as observed in Burkitt-Lymphoma, [12])
Remark 17 (Importance of self-renewal for evolution of leukemia). The case a 
The examples listed above also fulfill this more general condition.
System with 4 equations
The results about destabilization of the healthy steady state holds for arbitrary compartment numbers. To obtain insight into dynamics of the considered system, we perform linear stability analysis. Due to technical complexity of large systems, we focus on the case n = 2, m = 2 in the remainder of this paper. This is the minimal set of equations describing the healthy and leukemic hematopoiesis. Numerical simulations for wide parameter ranges suggest that a reduced model consisting only of two differentiation steps for each cell lineage shows dynamics qualitatively similar to the models consisting of more equations.
Proposition 20 (Linear stability of purely leukemic steady state). Assume 
Remark 21. Assumption (i) is necessary and sufficient for establishment of a leukemic cell line, see Proposition 11. Assumptions (ii) and (iii) are necessary and sufficient for existence of a healthy steady state, see Proposition 8.
Proof. The existence of a unique healthy steady state follows from Proposition 8. Assumption (ii) is equivalent to
Due to the symmetry of the considered ODE system with respect to interchange of c i and l i this and application of Proposition 8 lead to existence and uniqueness of the purely leukemic steady state.
Sincec 1 =c 2 = 0 and, due to the steady state condition, (2a
, the characteristic polynomial of the linearization around the purely leukemic steady state calculates as: 
Linearized stability analysis of composite steady states
In this Section we study stability of composite steady states. For simplicity of calculations we set 2 > 0,
Then the characteristic polynomial of the linearization around the composite steady state is of the form:
Remark 23. We observe that χ M has one zero eigenvalue.
Proposition 24 (Center Manifold). If there exists only one eigenvalue with zero real part, then the manifold of the steady states is a center manifold.
The proof is presented in the Appendix. We continue to analyze the eigenvalues of
We intend to use the Routh-Hurwitz-Criterion, [29] , and therefore calculate Hurwitz determinants ofχ M (λ).
(ii) The quadratic term a 2 ofχ M (λ) is positive. [7, 21, 9] . Mathematical studies and experimental evidence suggest that the hematopoietic system may exhibit chaos and instability [3, 45, 60] 
Remark 32. For a long time there exists the hypothesis that instability and chaos may play a role in cancer formation
Numerical Solutions
This Section is devoted to presentation of the numerical solutions of important cases of the proposed model. Numerics are based on the explicit Runge-Kutta Method. To obtain insight into the dynamics, p 10 . Numerical simulations demonstrate that for wide parameter ranges dynamics of systems with more compartments are qualitatively similar to the presented case. In the 2 × 2 case, the first compartment corresponds to a mixture of stem-and progenitor cells. Figure 1 gives an example of the case where leukemic stem cells have enhanced self-renewal potential and decreased proliferative activity compared to healthy stem cells. Numerical solutions show a clinically insignificant phase with normal healthy and low leukemic cell counts followed by a sudden rise of leukemic and a sudden reduction of healthy cell counts. This behavior is comparable to this seen in acute leukemias, such as AML. Figure 2 gives an example of the extinction of a mutated cell clone. In comparison to the healthy stem cells, the mutated cells show reduced self-renewal and enhanced proliferation. In this example, enhanced proliferation is not sufficient to compensate for reduced self-renewal potential. This example demonstrates the complex interplay of different cell properties that is necessary for persistence of the mutant clone. The numerical solution shows decrease of the mutant cell clone in a relatively short time scale. This scenario describes a benign mutation. The changes of healthy cell counts are negligible on the clinically relevant scale. Figure 3 depicts the coexistence of healthy and leukemic cell populations in equilibrium. Numerical solutions show a moderate and slow change of healthy cell counts to a new equilibrium. This scenario is comparable to preleukemic states, myelodysplasias, monoclonal gammopathy of unknown significance or the so-called smoldering myelomas [38, 10] that can persist for years without major impairment of blood function. Transformation to leukemia is possible if parameters change in favor of the leukemic population, e.g., by mutation and selection. Re-establishment of the healthy equilibrium is possible if parameters change in favor of the healthy population. Since this scenario requires a sharp condition on the parameters, it can be considered a rare case. Figures 5 and 6 compare reaction of the system to small perturbations of the composite steady state. Depending on parameters and initial conditions small perturbations of initial conditions lead to convergence to nearby steady-states (see Figure 5 ), or to convergence to relatively distant steady states (see Figure 6 ). The latter case occurs for specific parameter conditions only and therefore might not be observed in healthy organisms. 
Purely leukemic steady state
Re-establishment of the healthy steady state
Coexistence
Conclusions
We proposed a mathematical model describing time evolution of a leukemic cell line competing with healthy hematopoiesis. The model is based on qualitative measurable cell properties such as fractions of self-renewal, proliferation rates and death rates of the cell types considered. Interaction of the competing cell lines is modeled using nonlinear negative feedback signaling motivated by cytokine dynamics in hematopoiesis. Tools of linear stability analysis provide sufficient and necessary conditions for destabilization of the healthy equilibrium and expansion of a mutated cell clone. These conditions allow comparing the properties of leukemia initiating cells to those of the physiological adult stem cells.
Different kinds of steady states can appear in the model, depending on the model parameters. In most cases there exists a unique healthy and a unique purely leukemic steady state, but no composite steady states. We performed linear stability analysis for a version of the model including hematopoietic stem cells, mature blood cells, leukemic stem cells and non-stem leukemic cells. In absence of composite steady states, the leukemic steady state is locally stable if the healthy steady state is destabilized in the direction of the leukemic stem cell population.
The appearance of composite steady states is characterized by existence of one zero eigenvalue and a one dimensional manifold of steady states, which is locally equivalent to a center manifold. The composite steady state can be interpreted as a preleukemic state or a chronic disease such as myelodysplastic syndrome or MGUS. There exist composite steady states with positive real parts of some eigenvalues. If the proliferation rate of stem cells is large enough or the amount of leukemic stem cells is small enough, composite steady states are linearly stable. This result might give qualitative hints for therapeutic approaches.
Analysis of the model results in different scenarios of leukemic cell growth, among which the enhanced proliferation of malignant cells is the most prominent one. Nevertheless different scenarios are possible, such as induction of apoptosis or enhanced self-renewal. Enhanced self-renewal can partly compensate for reduced proliferation rates of malignant cells compared to healthy cells and vice versa. The case of reduced proliferation and enhanced self-renewal is of major biological interest, since it gives a putative explanation for intrinsic resistance of some cancers to cytotoxic treatment. Myelodysplastic syndromes are one example of this scenario [16, 26, 37, 19, 36] . Enhancement of self-renewal allows to establish a population of leukemic stem cells dividing slower than healthy stem cells and being therefore protected from cytotoxic agents. This also explains why dose acceleration of decitabine from the hypomethylating to the cytotoxic mode of action leads to a reduced outcome [16, 36] , especially since hypomethylation seems to interfere with self-renewal [13] .
The proposed model provides a rigorous framework for a systematic investigation of different scenarios of cancer initiation and to give putative answers to questions posed in the field of clinical applications. Diversity of scenarios described by the proposed model reflects the clinical hetero-geneity between different types of leukemias. This is a first step to respond to the need to develop specific treatment strategies dependent on the properties of malignant cells.
. Since on each point on the manifold of steady states the system is in an equilibrium the manifold is invariant under the flow of the system. Therefore the manifold of steady states is a center manifold in the case where only one eigenvalue has zero real part.
B Proof of Lemma 25
We use notations from equation 
